Skip to content

Decoy Therapeutics Inc.: filings

Every Decoy Therapeutics Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 47 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-12fiscal Q2 202631900001193125-26-346852
10-Q2026-05-08fiscal Q1 202629620001193125-26-214816
10-K2026-03-31fiscal FY 202531630001193125-26-134897
10-Q2025-11-14fiscal Q3 202528860001615219-25-000164
10-Q2025-08-12fiscal Q2 202527800001615219-25-000096
10-Q2025-05-14fiscal Q1 202527580001615219-25-000048
10-K2025-03-21fiscal FY 202428580001615219-25-000037
10-Q2024-11-14fiscal Q3 202427840001615219-24-000089
10-Q2024-08-09fiscal Q2 202427800001615219-24-000071
10-Q2024-05-13fiscal Q1 202427580001615219-24-000040
10-K2024-03-22fiscal FY 202329600001615219-24-000025
10-Q2023-11-09fiscal Q3 202328850001615219-23-000071
10-Q2023-08-10fiscal Q2 202327800001615219-23-000061
10-Q2023-05-11fiscal Q1 202328600001615219-23-000038
10-K2023-03-27fiscal FY 202231640001615219-23-000030
10-Q2022-11-10fiscal Q3 202230920001615219-22-000150
10-Q2022-08-05fiscal Q2 202230880001615219-22-000124
10-Q2022-05-12fiscal Q1 202231660001615219-22-000079
10-K2022-03-25fiscal FY 202133680001615219-22-000028
10-Q2021-11-04fiscal Q3 202130920001615219-21-000093
10-Q2021-08-05fiscal Q2 202130880001615219-21-000080
10-Q2021-05-12fiscal Q1 202126560001615219-21-000049
10-K2021-03-18fiscal FY 202033670001615219-21-000026
10-Q2020-11-12fiscal Q3 202030840001615219-20-000113
10-Q2020-08-12fiscal Q2 202027740001615219-20-000085
10-Q/A2020-05-15fiscal Q1 202027580001615219-20-000061
10-K2020-03-23fiscal FY 201932640001615219-20-000014
10-Q2019-11-12fiscal Q3 201932870001615219-19-000054
10-Q2019-07-17fiscal Q2 201932880001615219-19-000024
10-Q2019-05-01fiscal Q1 201932680001615219-19-000020
10-K2019-03-06fiscal FY 2018361410001615219-19-000008
10-Q2018-11-05fiscal Q3 201835870001615219-18-000061
10-Q2018-08-01fiscal Q2 201835870001615219-18-000052
10-Q2018-05-02fiscal Q1 201832660001615219-18-000032
10-K2018-03-07fiscal FY 2017341260001615219-18-000018
10-Q2017-11-06fiscal Q3 201732800001615219-17-000080
10-Q2017-08-02fiscal Q2 201732800001615219-17-000067
10-Q2017-05-03fiscal Q1 201732640001615219-17-000032
10-K2017-03-08fiscal FY 2016361300001615219-17-000021
10-Q2016-11-02fiscal Q3 201633820001615219-16-000226
10-Q2016-08-03fiscal Q2 201633820001615219-16-000218
10-Q2016-05-04fiscal Q1 201630600001615219-16-000162
10-K2016-03-08fiscal FY 2015311040001615219-16-000118
10-Q2015-11-04fiscal Q3 201528710001615219-15-000073
10-Q2015-08-05fiscal Q2 201527680001615219-15-000039
10-Q2015-05-06fiscal Q1 201526520001615219-15-000012
10-K2015-03-24fiscal FY 201430510001615219-15-000004

Inspect the source

Entity
Decoy Therapeutics Inc. / CIK 0001615219
Captured
2026-09-21T17:20:32.388Z
SEC response SHA-256
3dae29679ef228e32bff301a79640d7e283fcc5b87c08a4882faedfce1c66e98

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001615219.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))